Journal article · 2026
Real‐World Safety of JAK Inhibitors in Skin Immune‐Mediated Inflammatory Diseases: Boxed Warning Outcomes from a Multinational Cohort Study
Clinical Pharmacology & Therapeutics, 119(6), 1628–1637 · Published 14 March 2026 · DOI 10.1002/cpt.70258
In brief
“Real‐World Safety of JAK Inhibitors in Skin Immune‐Mediated Inflammatory Diseases: Boxed Warning Outcomes from a Multinational Cohort Study” is a 2026 journal article by Teng‐Li Lin and 5 co-authors, published in Clinical Pharmacology & Therapeutics. OpenAlex counts 7 citations as of 18 November 2026, which puts it in the top 2% of works published in 2026 by citations. The publisher's version is not open access, and OpenAlex records no free legal copy.
- Citations
- 7
- Most cited in
- 2026 (7)
- Field-weighted impact
- 11.47
- References
- 50
- Authors
- 6
Abstract
Janus kinase inhibitors (JAKis) have emerged as effective treatments for several skin immune-mediated inflammatory diseases (IMIDs). However, safety concerns have been raised due to boxed warnings from rheumatoid arthritis trials, and whether these risks apply to skin IMIDs remains uncertain. This multinational retrospective cohort study used the TriNetX database to compare the real-world safety of… Read the full abstract at the publisher.
Excerpt. This paper is not open access.
Cite this paper
Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.
APA 7
Lin, T., Fan, Y., Fan, K.-S., Juan, C., Chen, Y., & Wu, C. (2026). Real‐World Safety of JAK Inhibitors in Skin Immune‐Mediated Inflammatory Diseases: Boxed Warning Outcomes from a Multinational Cohort Study. Clinical Pharmacology & Therapeutics, 119(6), 1628–1637. https://doi.org/10.1002/cpt.70258
MLA 9
Lin, Teng‐Li, et al. “Real‐World Safety of JAK Inhibitors in Skin Immune‐Mediated Inflammatory Diseases: Boxed Warning Outcomes from a Multinational Cohort Study.” Clinical Pharmacology & Therapeutics, vol. 119, no. 6, 2026, pp. 1628–1637. https://doi.org/10.1002/cpt.70258.
Chicago
Lin, Teng‐Li, Yi‐Hsuan Fan, Kuo-Sheng Fan, Chao‐Kuei Juan, Yi–Ju Chen, and Chun‐Ying Wu. 2026. “Real‐World Safety of JAK Inhibitors in Skin Immune‐Mediated Inflammatory Diseases: Boxed Warning Outcomes from a Multinational Cohort Study.” Clinical Pharmacology & Therapeutics 119 (6): 1628–1637. https://doi.org/10.1002/cpt.70258.
Harvard
Lin, T. et al. (2026) ‘Real‐World Safety of JAK Inhibitors in Skin Immune‐Mediated Inflammatory Diseases: Boxed Warning Outcomes from a Multinational Cohort Study’, Clinical Pharmacology & Therapeutics, 119(6), pp. 1628–1637. doi:10.1002/cpt.70258.
IEEE
T. Lin, Y. Fan, K.-S. Fan, C. Juan, Y. Chen, and C. Wu, “Real‐World Safety of JAK Inhibitors in Skin Immune‐Mediated Inflammatory Diseases: Boxed Warning Outcomes from a Multinational Cohort Study,” Clinical Pharmacology & Therapeutics, vol. 119, no. 6, pp. 1628–1637, 2026, doi: 10.1002/cpt.70258.
BibTeX
@article{lin2026real,
title = {{Real‐World Safety of JAK Inhibitors in Skin Immune‐Mediated Inflammatory Diseases: Boxed Warning Outcomes from a Multinational Cohort Study}},
author = {Lin, Teng‐Li and Fan, Yi‐Hsuan and Fan, Kuo-Sheng and Juan, Chao‐Kuei and Chen, Yi–Ju and Wu, Chun‐Ying},
journal = {Clinical Pharmacology \& Therapeutics},
year = {2026},
volume = {119},
number = {6},
pages = {1628--1637},
doi = {10.1002/cpt.70258},
url = {https://doi.org/10.1002/cpt.70258}
}
Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)
Topic and keywords
Life Sciences › Immunology and Microbiology › Immunology › Psoriasis: Treatment and Pathogenesis
- JAK inhibitors
- psoriatic disease
- atopic dermatitis
- alopecia areata
- black box warning
- real-world safety
- tofacitinib
- upadacitinib
Work with this paper
Most-cited papers in Immunology and Microbiology
- Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4Ulrich K. Laemmli · Nature · 1970 · 249,784 citations
- Atherosclerosis — An Inflammatory DiseaseRussell Ross · New England Journal of Medicine · 1999 · 21,957 citations
- Continuous cultures of fused cells secreting antibody of predefined specificityGeorges Köhler, César Milstein · Nature · 1975 · 17,450 citations
- Inflammation and cancerLisa M. Coussens, Zena Werb · Nature · 2002 · 15,462 citations
- Dendritic cells and the control of immunityJacques Banchereau, Ralph M. Steinman · Nature · 1998 · 14,526 citations
Questions about this paper
How do I cite this paper in APA style?
Lin, T., Fan, Y., Fan, K.-S., Juan, C., Chen, Y., & Wu, C. (2026). Real‐World Safety of JAK Inhibitors in Skin Immune‐Mediated Inflammatory Diseases: Boxed Warning Outcomes from a Multinational Cohort Study. Clinical Pharmacology & Therapeutics, 119(6), 1628–1637. https://doi.org/10.1002/cpt.70258
How many times has this paper been cited?
7 times, according to OpenAlex on 18 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.
Is this paper free to read?
OpenAlex records no free legal copy. Check your library's access, the authors' pages or a repository, or ask the corresponding author for a copy.
Who wrote this paper?
Teng‐Li Lin, Yi‐Hsuan Fan, Kuo-Sheng Fan, Chao‐Kuei Juan, Yi–Ju Chen, Chun‐Ying Wu.
What is the DOI of this paper?
10.1002/cpt.70258, permanently at https://doi.org/10.1002/cpt.70258. Sign in and open it from this page.
Bibliographic data from OpenAlex (CC0), last checked 18 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.